Y Intercept (Hong Kong) LTD Incyte Corp Transaction History

Y Intercept (Hong Kong) LTD

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$51.18 - $63.75 $645,226 - $803,696	12,607 Added 49.45%	38,104 $2.31 Million
Q1 2024 May 10, 2024	BUY	$56.55 - $66.59 $1.44 Million - $1.7 Million	25,497 New	25,497 $1.45 Million
Q3 2023 Nov 14, 2023	BUY	$57.77 - $65.93 $272,558 - $311,057	4,718 Added 65.95%	11,872 $685,000
Q2 2023 Aug 14, 2023	SELL	$60.95 - $75.51 $1.32 Million - $1.63 Million	-21,644 Reduced 75.16%	7,154 $445,000
Q1 2023 May 09, 2023	BUY	$70.23 - $86.01 $664,516 - $813,826	9,462 Added 48.93%	28,798 $2.08 Million
Q4 2022 Feb 14, 2023	SELL	$67.18 - $84.11 $332,742 - $416,596	-4,953 Reduced 20.39%	19,336 $1.55 Million
Q3 2022 Feb 14, 2023	BUY	$66.18 - $82.86 $1.61 Million - $2.01 Million	24,289 New	24,289 $1.62 Million
Q2 2022 Aug 08, 2022	SELL	$66.18 - $83.18 $798,263 - $1 Million	-12,062 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$66.02 - $79.71 $345,350 - $416,963	-5,231 Reduced 30.25%	12,062 $958,000
Q4 2021 Feb 14, 2022	BUY	$63.34 - $74.11 $597,422 - $699,005	9,432 Added 119.98%	17,293 $1.27 Million
Q3 2021 Nov 15, 2021	SELL	$68.67 - $84.02 $21,081 - $25,794	-307 Reduced 3.76%	7,861 $541,000
Q2 2021 Aug 26, 2021	BUY	$79.87 - $87.53 $652,378 - $714,945	8,168 New	8,168 $687,000
Q2 2021 Aug 12, 2021	BUY	$79.87 - $87.53 $0 - $0	0 New	0 $687,000

652

186M

714K

557K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16.1B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Y Intercept (Hong Kong) LTD, based on Form 13F filings with the SEC.

Stay updated on Y Intercept (Hong Kong) LTD with notifications on news.